# EIDP, Inc.: overview

CTA-PB · NYSE · CIK 30554 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cta-pb.md) · [Financials](/companies/cta-pb/financials.md) · [Filings](/companies/cta-pb/filings.md) · [Insiders](/companies/cta-pb/insiders.md)

Latest reported revenue: [$6.29bn](/filings/0000030554-19-000017.md) for Q1 FY2019, three months to 2019-03-31, from the 10-Q filed May 8, 2019 (XBRL us-gaap:Revenues, accession 0000030554-19-000017).

## Last eight quarters

| Line item | Unit | Q1 FY2016 (2016-03-31) | Q2 FY2016 (2016-06-30) | Q3 FY2016 (2016-09-30) | Q4 FY2016 (2016-12-31) | Q1 FY2017 (2017-03-31) | Q2 FY2017 (2017-06-30) | period not labelled (2018-03-31) | Q1 FY2019 (2019-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [7,405](/filings/0000030554-17-000016.md) | [7,061](/filings/0000030554-17-000035.md) | [4,917](/filings/0000030554-17-000004.md) | [5,211](/filings/0000030554-17-000004.md) | [7,743](/filings/0000030554-17-000016.md) | [7,424](/filings/0000030554-17-000035.md) | [6,699](/filings/0000030554-19-000017.md) | [6,288](/filings/0000030554-19-000017.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [16.6%](/filings/0000030554-17-000016.md) | [14.4%](/filings/0000030554-17-000035.md) | [0.0%](/filings/0000030554-16-000156.md) | [5.0%](/filings/0000030554-17-000004.md) | [14.4%](/filings/0000030554-17-000016.md) | [11.6%](/filings/0000030554-17-000035.md) | [(3.4%)](/filings/0000030554-19-000017.md) | [1.4%](/filings/0000030554-19-000017.md) |
| Diluted EPS | $ per share | [1.39](/filings/0000030554-17-000016.md) | [1.16](/filings/0000030554-17-000035.md) | [0.00](/filings/0000030554-16-000156.md) | not reported | [1.27](/filings/0000030554-17-000016.md) | [0.99](/filings/0000030554-17-000035.md) | not reported | not reported |
| Free cash flow | $m | [(2,163)](/filings/0000030554-17-000016.md) | [196 d](/filings/0000030554-17-000035.md) | [131 d](/filings/0000030554-16-000156.md) | [4,117 d](/filings/0000030554-17-000004.md) | [(1,954)](/filings/0000030554-17-000016.md) | [(2,625) d](/filings/0000030554-17-000035.md) | [(2,330)](/filings/0000030554-19-000017.md) | [(2,047)](/filings/0000030554-19-000017.md) |

- Revenue. XBRL Revenue: us-gaap:SalesRevenueNet; Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:SalesRevenueNet; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:SalesRevenueNet; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:SalesRevenueNet; Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2012 (2012-12-31) | FY2013 (2013-12-31) | FY2014 (2014-12-31) | FY2015 (2015-12-31) | FY2016 (2016-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [34.8](/filings/0000030554-15-000004.md) | [29.0](/filings/0000030554-16-000106.md) | [28.4](/filings/0000030554-17-000004.md) | [25.1](/filings/0000030554-17-000004.md) | [24.6](/filings/0000030554-17-000004.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [15.4%](/filings/0000030554-15-000004.md) | [18.5%](/filings/0000030554-15-000004.md) | [22.4%](/filings/0000030554-15-000004.md) | not reported | not reported |
| Net margin | % | [7.9%](/filings/0000030554-15-000004.md) | [16.7%](/filings/0000030554-16-000106.md) | [12.8%](/filings/0000030554-17-000004.md) | [7.8%](/filings/0000030554-17-000004.md) | [10.2%](/filings/0000030554-17-000004.md) |
| Diluted EPS | $ per share | [2.91](/filings/0000030554-15-000004.md) | [5.18](/filings/0000030554-16-000106.md) | [3.92](/filings/0000030554-17-000004.md) | [2.16](/filings/0000030554-17-000004.md) | [2.85](/filings/0000030554-17-000004.md) |
| Free cash flow | $bn | [3.1](/filings/0000030554-15-000004.md) | [1.3](/filings/0000030554-16-000106.md) | [1.7](/filings/0000030554-17-000004.md) | [0.7](/filings/0000030554-17-000004.md) | [2.3](/filings/0000030554-17-000004.md) |

- Revenue. XBRL Revenue: us-gaap:SalesRevenueNet.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:SalesRevenueNet.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:SalesRevenueNet.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:SalesRevenueNet.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cta-pb/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

None of the funds in coverage reports a position in its latest 13F.

## Recent filings

[All 2,026 filings](/companies/cta-pb/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 06:30 ET | [8-K](/filings/0001193125-26-419637.md) | 8.01 Other events | 0001193125-26-419637 |
| 2026-10-07 | 17:09 ET | [8-K](/filings/0001193125-26-417064.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-417064 |
| 2026-10-07 | 17:07 ET | [8-K](/filings/0001193125-26-417062.md) | 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-417062 |
| 2026-10-05 | 17:27 ET | [8-K](/filings/0001193125-26-414490.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001193125-26-414490 |
| 2026-10-01 | 17:25 ET | [8-K](/filings/0001755672-26-000028.md) | 9.01 Financial statements and exhibits | 0001755672-26-000028 |
| 2026-10-01 | 08:14 ET | [8-K](/filings/0001193125-26-409895.md) | 8.01 Other events | 0001193125-26-409895 |
| 2026-10-01 | 07:42 ET | [8-K](/filings/0001193125-26-409840.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-409840 |
| 2026-10-01 | 21:36 ET | [8-K](/filings/0001193125-26-409549.md) | 8.01 Other events | 0001193125-26-409549 |
| 2026-09-30 | 13:03 ET | [8-K](/filings/0001193125-26-408740.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-408740 |
| 2026-09-25 | 07:49 ET | [8-K](/filings/0001193125-26-401618.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-401618 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001755672-26-000004.md), filed Feb 12, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 30554
- Tickers: CTA-PB, CTA-PA
- Exchange: NYSE
- SIC code: 2820 Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)
- State of incorporation: DE
- Filer category: not reported

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.